Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

905 studies match

clinicaltrialsPublishedShowing 651–700 of 905 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02294786	Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer	terminated	Phase 2	62	Novartis PharmaceuticalsINDUSTRY	5	Jul 15, 2019	clinicaltrials
NCT01282424	Efficacy and Safety Study of Idelalisib in Participants With Indolent B-Cell Non-Hodgkin Lymphomas(DELTA)	completed	Phase 2	125	Gilead SciencesINDUSTRY	6